Prévisions du marché des laboratoires cliniques de référence en Asie-Pacifique jusqu\'en 2031 - Analyse régionale - par prestataire de services (en milieu hospitalier, autonome et en clinique) et application (médecine de laboratoire, essais cliniques et autres)
Les initiatives stratégiques avec les laboratoires de référence stimulent le marché des laboratoires cliniques de référence en Asie-Pacifique
Les initiatives stratégiques des prestataires de services de laboratoire telles que l\'acquisition, l\'alliance et l\'expansion avec les laboratoires de référence sont parmi les moyens les plus rentables d\'obtenir les avantages d\'une meilleure prise en charge des patients et d\'une meilleure efficacité des coûts. En 2024, Hausen-Bernstein Co. Ltd., le principal fournisseur de produits de diagnostic in vitro (« IVD ») en Thaïlande, a été acquis par Everlife Holdings Pte Ltd, une importante entreprise d\'accès au marché et de distribution en Inde et en Asie du Sud-Est. En 2024, CORE Diagnostics, une société de diagnostic de nouvelle génération pour la sélection de médicaments et la stratification des maladies basée en Inde, a annoncé son intention d\'étendre ses opérations dans 50 nouvelles villes. En 2023, Suburban Diagnostics a ouvert son plus grand laboratoire de « référence » à Vidya Vihar, Mumbai. Ce laboratoire ultramoderne utilisera des technologies de test et d\'automatisation des processus de pointe pour fournir un menu de tests complet pour un diagnostic précis et rapide. En 2023, TRUSTlab Diagnostics, un laboratoire de référence clinique à Hyderabad, en Inde, s\'est associé à NKV Path Labs à Gurugram pour étendre ses services de diagnostic aux zones mal desservies du pays. Ainsi, le nombre croissant d\'acquisitions et d\'alliances avec des laboratoires de référence devrait offrir d\'importantes opportunités de croissance du marché.
Aperçu du marché des laboratoires de référence clinique en Asie-Pacifique
Au cours des dernières décennies, l\'émergence de plusieurs maladies infectieuses, dont la COVID-19 et la variole du singe, a posé un nouveau risque pour la santé humaine. La Chine a connu un changement épidémiologique rapide, avec des avancées notables dans le contrôle des maladies infectieuses. Français Lorsqu\'il s\'agit de maladies infectieuses, il est essentiel de détecter et de localiser l\'épidémie le plus rapidement possible, d\'identifier l\'agent pathogène et d\'assurer une élimination appropriée pour minimiser l\'escalade et prévenir et gérer les maladies infectieuses. Divers tests sont effectués dans les hôpitaux ou les laboratoires de référence pour détecter l\'agent pathogène. Selon les divisions administratives au niveau provincial (PLAD), 5 770 cas de paludisme ont été enregistrés entre 2014 et 2021, avec 99,05 % des échantillons de paludisme soumis aux laboratoires provinciaux de référence pour le diagnostic du paludisme. Les laboratoires provinciaux de référence pour le diagnostic du paludisme ont joué un rôle essentiel pour garantir l\'exactitude et la fiabilité du diagnostic du Plasmodium dans les établissements de santé. Les facteurs mentionnés ci-dessus stimulent le marché des laboratoires de référence clinique dans le pays.
Chiffre d\'affaires et prévisions du marché des laboratoires de référence clinique en Asie-Pacifique jusqu\'en 2031 (en millions de dollars américains)
Segmentation du marché des laboratoires de référence clinique en Asie-Pacifique
Le marché des laboratoires de référence clinique en Asie-Pacifique est classé en prestataire de services, application et pays.
Sur la base du fournisseur de services, le marché des laboratoires de référence clinique de l\'Asie-Pacifique est segmenté en hôpitaux, autonomes et cliniques. Le segment hospitalier détenait la plus grande part de marché en 2023.
En termes d\'application, le marché des laboratoires de référence clinique de l\'Asie-Pacifique est classé en médecine de laboratoire, essais cliniques et autres. Le segment de la médecine de laboratoire détenait la plus grande part de marché en 2023.
Par pays, le marché des laboratoires de référence clinique de l\'Asie-Pacifique est segmenté en Chine, Japon, Inde, Australie, Corée du Sud et reste de l\'Asie-Pacifique. La Chine a dominé la part de marché des laboratoires de référence clinique de l\'Asie-Pacifique en 2023.
Sonic Healthcare Ltd, Laboratory Corp of America Holdings, Quest Diagnostics Inc et Myraid Genetics Inc sont quelques-unes des principales sociétés opérant sur le marché des laboratoires de référence clinique de l\'Asie-Pacifique.
TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Asia Pacific Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Clinical Reference Laboratory Market - Key Market Dynamics
4.1 Market Drivers
4.1.1 Rising Prevalence of Chronic and Infectious Diseases
4.1.2 Increasing Number of Clinical Trials
4.2 Market Restraints
4.2.1 Complications Related to Regulatory Framework and Adoption of Continuous Technological Developments
4.3 Market Opportunities
4.3.1 Strategic Initiatives with Reference Laboratories
4.4 Future Trends
4.4.1 Use of Artificial Intelligence in Clinical Reference Laboratories
4.5 Impact of Drivers and Restraints:
5. Clinical Reference Laboratory Market - Asia Pacific Analysis
5.1 Clinical Reference Laboratory Market Revenue (US$ Million), 2021-2031
5.2 Clinical Reference Market Forecast and Analysis
6. Clinical Reference Laboratory Market Analysis - by Service Provider
6.1 Overview
6.2 Hospital-Based
6.2.1 Overview
6.2.2 Hospital-Based: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
6.3 Standalone
6.3.1 Overview
6.3.2 Standalone: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
6.4 Clinical Based
6.4.1 Overview
6.4.2 Clinical Based: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
7. Asia Pacific Clinical Reference Laboratory Market Analysis - by Application
7.1 Overview
7.2 Laboratory Medicine
7.2.1 Overview
7.2.2 Laboratory Medicine: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
7.3 Clinical Trials
7.3.1 Overview
7.3.2 Clinical Trials: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
7.4 Others
7.4.1 Overview
7.4.2 Others: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
8. Asia Pacific Clinical Reference Laboratory Market - Country Analysis
8.1 Asia Pacific Clinical Reference Laboratory Market Overview
8.1.1 Asia Pacific: Clinical Reference Laboratory Market Breakdown 2023 and 2031 (%) - by Country
8.1.1.1 China: Clinical Reference Laboratory Market - Overview
8.1.1.2 China: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
8.1.1.2.1 China: Clinical Reference Laboratory Market Revenue and Forecast to 2031 (US$ Million), by Service Provider
8.1.1.2.2 China: Clinical Reference Laboratory Market Revenue and Forecast to 2031 (US$ Million), by Application
8.1.1.3 Japan: Clinical Reference Laboratory Market - Overview
8.1.1.4 Japan: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
8.1.1.4.1 Japan: Clinical Reference Laboratory Market Revenue and Forecast to 2031 (US$ Million), by Service Provider
8.1.1.4.2 Japan: Clinical Reference Laboratory Market Revenue and Forecast to 2031 (US$ Million), by Application
8.1.1.5 India: Clinical Reference Laboratory Market - Overview
8.1.1.6 India: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
8.1.1.6.1 India: Clinical Reference Laboratory Market Revenue and Forecast to 2031 (US$ Million), by Service Provider
8.1.1.6.2 India: Clinical Reference Laboratory Market Revenue and Forecast to 2031 (US$ Million), by Application
8.1.1.7 Australia: Clinical Reference Laboratory Market - Overview
8.1.1.8 Australia: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
8.1.1.8.1 Australia: Clinical Reference Laboratory Market Revenue and Forecast to 2031 (US$ Million), by Service Provider
8.1.1.8.2 Australia: Clinical Reference Laboratory Market Revenue and Forecast to 2031 (US$ Million), by Application
8.1.1.9 South Korea: Clinical Reference Laboratory Market - Overview
8.1.1.10 South Korea: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
8.1.1.10.1 South Korea: Clinical Reference Laboratory Market Revenue and Forecast to 2031 (US$ Million), by Service Provider
8.1.1.10.2 South Korea: Clinical Reference Laboratory Market Revenue and Forecast to 2031 (US$ Million), by Application
8.1.1.11 Rest of APAC: Clinical Reference Laboratory Market - Overview
8.1.1.12 Rest of APAC: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
8.1.1.12.1 Rest of APAC: Clinical Reference Laboratory Market Revenue and Forecast to 2031 (US$ Million), by Service Provider
8.1.1.12.2 Rest of APAC: Clinical Reference Laboratory Market Revenue and Forecast to 2031 (US$ Million), by Application
9. Clinical Reference Laboratory Market-Industry Landscape
9.1 Overview
9.2 Growth Strategies in the Clinical Reference Laboratory Market
9.3 Inorganic Growth Strategies
9.3.1 Overview
9.4 Organic Growth Strategies
9.4.1 Overview
10. Company Profiles
10.1 Sonic Healthcare Ltd
10.1.1 Key Facts
10.1.2 Business Description
10.1.3 Products and Services
10.1.4 Financial Overview
10.1.5 SWOT Analysis
10.1.6 Key Developments
10.2 Laboratory Corp of America Holdings
10.2.1 Key Facts
10.2.2 Business Description
10.2.3 Products and Services
10.2.4 Financial Overview
10.2.5 SWOT Analysis
10.2.6 Key Developments
10.3 Quest Diagnostics Inc
10.3.1 Key Facts
10.3.2 Business Description
10.3.3 Products and Services
10.3.4 Financial Overview
10.3.5 SWOT Analysis
10.3.6 Key Developments
10.4 Myraid Genetics Inc
10.4.1 Key Facts
10.4.2 Business Description
10.4.3 Products and Services
10.4.4 Financial Overview
10.4.5 SWOT Analysis
10.4.6 Key Developments
11. Appendix
11.1 About The Insight Partners
11.2 Glossary of Terms
List of Tables
Table 1. Asia Pacific Clinical Reference Laboratory Market Segmentation
Table 2. Clinical Reference Market - Revenue and Forecast to 2031 (US$ Million)
Table 3. China: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million) - by Service Provider
Table 4. China: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 5. Japan: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million) - by Service Provider
Table 6. Japan: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 7. India: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million) - by Service Provider
Table 8. India: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 9. Australia: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million) - by Service Provider
Table 10. Australia: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 11. South Korea: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million) - by Service Provider
Table 12. South Korea: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 13. Rest of APAC: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million) - by Service Provider
Table 14. Rest of APAC: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 15. Recent Inorganic Growth Strategies in the Clinical Reference Laboratory Market
Table 16. Recent Organic Growth Strategies in the Clinical Reference Laboratory Market
Table 17. Glossary of Terms
List of Figures
Figure 1. Asia Pacific Clinical Reference Laboratory Market Segmentation, by Country
Figure 2. Clinical Reference Laboratory Market - Key Market Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Clinical Reference Laboratory Market Revenue (US$ Million), 2021-2031
Figure 5. Clinical Reference Laboratory Market Share (%) - by Service Provider (2023 and 2031)
Figure 6. Hospital-Based: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
Figure 7. Standalone: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
Figure 8. Clinical Based: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
Figure 9. Clinical Reference Laboratory Market Share (%) - by Application (2023 and 2031)
Figure 10. Laboratory Medicine: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
Figure 11. Clinical Trials: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
Figure 12. Others: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
Figure 13. Asia Pacific: Clinical Reference Laboratory Market, by Key Country - Revenue (2023) (US$ Million)
Figure 14. Asia Pacific: Clinical Reference Laboratory Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 15. China: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
Figure 16. Japan: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
Figure 17. India: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
Figure 18. Australia: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
Figure 19. South Korea: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
Figure 20. Rest of APAC: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
Figure 21. Growth Strategies in the Clinical Reference Laboratory Market
- Sonic Healthcare Ltd
- Laboratory Corp of America Holdings
- Quest Diagnostics Inc
- Myraid Genetics Inc
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific clinical reference laboratory market.
- Highlights key business priorities to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific clinical reference laboratory market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the Asia Pacific clinical reference laboratory market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.